Fanconi Anemia Drug Market Is Estimated To Witness High Growth Owing To Increasing Research & Development Activities
Fanconi anemia is a rare genetic blood disorder characterized by bone marrow failure and increased risk of cancer. The drugs associated with the treatment of Fanconi anemia are used to treat symptoms and complications caused by the condition. Some key drugs include L-glutamine, andrographis, decitabine, lenalidomide, etc. that are used for hematopoietic stem cell transplantation, treatment of...
0 Reacties
0 aandelen